Track: Stem Cell and Gene Therapy

Stem Cell and Gene Therapy

The "Stem Cell and Gene Therapy" session will delve into the cutting-edge advancements in cancer treatment that harness the power of stem cells and gene therapy. As research in this field rapidly evolves and reshapes the oncology landscape, this session will provide a comprehensive overview of how advancing fields of stem cell research and gene therapies are being harnessed to combat cancer, highlighting their potential to revolutionize oncology and offer new hope to patients worldwide.

CSC Role in Tumorigenesis segment will explore their biology and role in initiating and sustaining tumors, and how targeting Cancer Stem Cells(CSCs) could lead to more effective treatments and potentially prevent cancer recurrence.

Autologous and Allogeneic Transplants are vital components of modern cancer therapy and this part of the session will discuss the differences between these two types of transplants, their applications, and the challenges associated with each to provide the latest advancements in transplant techniques that improve patient outcomes.

Stem Cell Treatment and Types discussion will also highlight the ethical considerations and regulatory challenges in stem cell research and treatment and will cover the different types of stem cells used in cancer therapy.

Personalized Gene Therapy segment will explore how to learn about the challenges of delivering gene therapy effectively, the progress in clinical trials, and the potential of this approach to provide long-term, personalized cancer care.

The discussion will include the use of Regenerative Medicine for Gene Transfer, as well as the potential of combining gene therapy with stem cell therapy to improve outcomes for cancer patients.

Oncolytic Virotherapy is an innovative approach and this portion will also explore insights into the prospects of oncolytic virotherapy as a component of multi-modal cancer treatment strategies.